Latest filing published 05 May 2016 for Viking Therapeutics, Inc., €12k.
Insider track record
No signal scores available.
Rochelle Hanley: trading record in brief
This profile gathers the share dealings of Rochelle Hanley in Viking Therapeutics, Inc. We count 4 filings; the first trade dates from 4 May 2015 and the latest from 4 May 2016.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 5 May 2016, reports a share grant of €12k in Viking Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rochelle Hanley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,595 shares@ US$1.31100.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-16-117867:0
- 158,453 sharesCommon Stock, par value $0.00001 per shareSEC:0001209191-15-039608:0
- 70,000 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-15-039608:1
- 7,308 shares@ US$9.49Common Stock, par value $0.00001 per shareSEC:0001209191-15-039608:2
4 of 4 declarations
